Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer-Reference-Cited by-同舟云学术

Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer

Published:2022-04 Issue:4 Volume:298 Page:101817
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Cha Jong-Ho,Chan Li-Chuan,Wang Ying-Nai^ORCID,Chu Yu-Yi,Wang Chie-Hong^ORCID,Lee Heng-Huan,Xia Weiya,Shyu Woei-Cherng,Liu Shih-Ping,Yao Jun,Chang Chiung-Wen,Cheng Fan-Ru,Liu Jielin,Lim Seung-Oe,Hsu Jennifer L.,Yang Wen-Hao,Hortobagyi Gabriel N.,Lin Chunru,Yang Liuqing,Yu Dihua,Jeng Long-Bin,Hung Mien-Chie

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference59 articles.

1. Breast cancer;Harbeck;Nat. Rev. Dis. primers,2019

2. Finding the positive in triple-negative breast cancer;Carey;Nat. Cancer,2021

3. Clinical relevance of host immunity in breast cancer: From TILs to the clinic;Savas;Nat. Rev. Clin. Oncol.,2016

4. Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers;Gruosso;J. Clin. Invest.,2019

5. Immunotherapy in triple-negative breast cancer;Emens;Cancer J.,2021

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Receptor Tyrosine Kinases as a Novel Strategy for the Treatment of Triple-Negative Breast Cancer;Technology in Cancer Research & Treatment;2024-01

2. Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential;Cancers;2023-12-26

3. Eph receptors and ephrins in cancer progression;Nature Reviews Cancer;2023-11-23

4. Development of an Anti-EphB4 Monoclonal Antibody for Multiple Applications Against Breast Cancers;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2023-10-01

5. EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets;Cancers;2023-08-04